Depression and assessement: statistical analysis and examination of credibility in the context of simulation and aggravation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00007708

Enrollment

300

Registered

2015-02-12

Start date

2014-10-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: Clinical sample: Patients with a depressive disorder (F 32, F 33), aged between 18 and 60 years. Methods: Diagnosis by using the IDCDL (Hiller et al., 1995). Afterwards all subjects fill o

same age.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Subjects must be aged between 18 and 60 years. Sufficient spoken and written speech comprehension of the German language must be guaranteed to ensure that the tests are understood by the subjects. Patients (N = 150): The diagnosis of a depressive disorder must be assured. Subjects can be hospital or ambulant or semiresidential (pschiatric and/or psychotherapeutic) patients. Controls (N = 150): Physical and mental healthy subjects without mental diseases in their ananmnesis.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patients: Acute suicidal tendencies, substance addiction, somatic illness including acute/chronic infectious diseases, autoimmune diseases, pregnancy, psychotic disorders, bipolar depression. Patients are additionally excluded if the primary diagnosis is post traumatic stress disorder, general anxiety disorder, social phobia or panic disorder. Other secundary psychiatric diagnosis are tolarated. Controls: Use of ataractics, somatic illness including acute/chronic infectious diseases, autoimmune diseases, pregnancy as well as mental diseases in their medical history.

Design outcomes

Primary

Measure	Time frame
Study aim: investigation of the fakeability respectively simulation (healthy controls) and aggravation (patients) of the most frequently used diagnostic tests in assessments concerning invalidity pension. Participants: N = 150 depressive subjects and N = 150 healthy controls. Method: Personality dimensions (NEO-FFI, Borkenau & Ostendorf, 1987), actual symptoms and mood (BDI-II, Hautzinger et al. 2005; SCL-90-R, Derogatis, 2002)), simulation tendencies (SFSS, Cima et al., 2003), cognitive performance (d-2-R, Brickencamp et al., 1998). Study duration: 11/01/14-04/30/16	—

Measure

Time frame

Study aim: investigation of the fakeability respectively simulation (healthy controls) and aggravation (patients) of the most frequently used diagnostic tests in assessments concerning invalidity pension. Participants: N = 150 depressive subjects and N = 150 healthy controls. Method: Personality dimensions (NEO-FFI, Borkenau & Ostendorf, 1987), actual symptoms and mood (BDI-II, Hautzinger et al. 2005; SCL-90-R, Derogatis, 2002)), simulation tendencies (SFSS, Cima et al., 2003), cognitive performance (d-2-R, Brickencamp et al., 1998). Study duration: 11/01/14-04/30/16

—

Secondary

Measure	Time frame
Construction of a new test by using those items which proved to be reliable and valid.	—

Countries

Germany

Contacts

Public ContactNina Sarubin

Klinik und Poliklinik für Psychiatrie und Psychotherapie der LMU München

nina.sarubin@med.uni-muenchen.de+49(0)89/200037377

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 4, 2026